T. Ree

Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values

John M Buermann, G. Marfia, H. Hartung, 2022, Clinical Neurophysiology.

Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial

Hester F. Lingsma, E. Steyerberg, R. Hughes, 2021, The Lancet Neurology.

Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial

P. Willems, W. Vandertop, R. M. Van den Berg-Vos, 2020, The Lancet.